These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33733242)

  • 21. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future prospects for CRISPR-based tools in bacteria.
    Luo ML; Leenay RT; Beisel CL
    Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 24. Current situation of biofuel production and its enhancement by CRISPR/Cas9-mediated genome engineering of microbial cells.
    Javed MR; Noman M; Shahid M; Ahmed T; Khurshid M; Rashid MH; Ismail M; Sadaf M; Khan F
    Microbiol Res; 2019 Feb; 219():1-11. PubMed ID: 30642460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coupling ssDNA recombineering with CRISPR-Cas9 for Escherichia coli DnaG mutations.
    Li J; Sun J; Gao X; Wu Z; Shang G
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3559-3570. PubMed ID: 30879090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient and Precise Genome Editing in
    Corts AD; Thomason LC; Gill RT; Gralnick JA
    ACS Synth Biol; 2019 Aug; 8(8):1877-1889. PubMed ID: 31277550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9-Assisted Seamless Genome Editing in Lactobacillus plantarum and Its Application in
    Zhou D; Jiang Z; Pang Q; Zhu Y; Wang Q; Qi Q
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444197
    [No Abstract]   [Full Text] [Related]  

  • 29. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering.
    Singh A; Chakraborty D; Maiti S
    Chem Soc Rev; 2016 Dec; 45(24):6666-6684. PubMed ID: 27711765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a RecE/T-Assisted CRISPR-Cas9 Toolbox for Lactobacillus.
    Huang H; Song X; Yang S
    Biotechnol J; 2019 Jul; 14(7):e1800690. PubMed ID: 30927506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The CRISPR-Cas system: beyond genome editing].
    Croteau FR; Rousseau GM; Moineau S
    Med Sci (Paris); 2018 Oct; 34(10):813-819. PubMed ID: 30451675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for genomic recombineering in Yersinia ruckeri using CRISPR Cas12a coupled with the Ī» Red system.
    Ejaz RN; Taylor NMI; Steiner-Rebrova EM
    STAR Protoc; 2024 Jun; 5(2):103014. PubMed ID: 38615317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli.
    Reisch CR; Prather KL
    Sci Rep; 2015 Oct; 5():15096. PubMed ID: 26463009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native CRISPR-Cas-Mediated Genome Editing Enables Dissecting and Sensitizing Clinical Multidrug-Resistant P.Ā aeruginosa.
    Xu Z; Li M; Li Y; Cao H; Miao L; Xu Z; Higuchi Y; Yamasaki S; Nishino K; Woo PCY; Xiang H; Yan A
    Cell Rep; 2019 Nov; 29(6):1707-1717.e3. PubMed ID: 31693906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas.
    Nievergelt AP; Diener DR; Bogdanova A; Brown T; Pigino G
    STAR Protoc; 2024 Mar; 5(1):102774. PubMed ID: 38096061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scarless Cas9 Assisted Recombineering (no-SCAR) in Escherichia coli, an Easy-to-Use System for Genome Editing.
    Reisch CR; Prather KLJ
    Curr Protoc Mol Biol; 2017 Jan; 117():31.8.1-31.8.20. PubMed ID: 28060411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both
    Huang W; Wang G; Sebra R; Zhuge J; Yin C; Aguero-Rosenfeld ME; Schuetz AN; Dimitrova N; Fallon JT
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microinjection for precision genome editing in
    Ghanta KS; Ishidate T; Mello CC
    STAR Protoc; 2021 Sep; 2(3):100748. PubMed ID: 34505086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.